Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

The introduction of liquid biopsies for the detection of EGFR mutations in non-small cell lung cancer patients (NSCLC) has revolutionized the clinical care. However, liquid biopsies are technically challenging and require specifically trained personnel. To facilitate the implementation of liquid bio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Simon Heeke, Véronique Hofman, Jonathan Benzaquen, Josiane Otto, Virginie Tanga, Katia Zahaf, Maryline Allegra, Elodie Long-Mira, Sandra Lassalle, Charles-Hugo Marquette, Marius Ilie, Paul Hofman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-04-01
coleção:	Frontiers in Pharmacology
Assuntos:	EGFR liquid biopsy idylla cobas plasma circulating tumor DNA
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2021.657743/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!